Clinical Trial: To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome

U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06840496) titled 'To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome' on Feb. 17.

Brief Summary: Primary Objective * To investigate the efficacy of treatment with oral Bionetide versus placebo in girls and women with Rett syndrome

Key Secondary Objective

* To investigate the efficacy of treatment with oral Bionetide versus placebo on ability to communicate in girls and women with Rett syndrome

Study Start Date: June 15, 2025

Study Type: INTERVENTIONAL

Condition: Rett Syndrome

Intervention: DRUG: Bionetide

Bionetide solution of 20-40 mL based on the subject's weight at Baseline, ...